Yang G - Search Results

1

Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease.

Thompson TC, Timme TL, Park SH, Yang G, Ren C. Thompson TC, et al. Among authors: yang g. Prostate. 2000 Jun 1;43(4):248-54. doi: 10.1002/1097-0045(20000601)43:4<248::aid-pros3>3.0.co;2-p. Prostate. 2000. PMID: 10861743 Review.

2

Regulation of apoptosis in prostatic disease.

Thompson TC, Yang G. Thompson TC, et al. Among authors: yang g. Prostate Suppl. 2000;9:25-8. doi: 10.1002/1097-0045(2000)45:9+<25::aid-pros6>3.0.co;2-5. Prostate Suppl. 2000. PMID: 11056499 Review.

3

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression.

Shaker MR, Yang G, Timme TL, Park SH, Kadmon D, Ren C, Ji X, Lee HM, Sehgal I, Anzano M, Sporn MB, Thompson TC. Shaker MR, et al. Among authors: yang g. Clin Exp Metastasis. 2000;18(5):429-38. doi: 10.1023/a:1010905309570. Clin Exp Metastasis. 2000. PMID: 11467776

4

In situ gene therapy for prostate cancer: immunomodulatory approaches.

Thompson TC, Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, Wheeler TM, Kadmon D. Thompson TC, et al. Among authors: yang g. Expert Opin Biol Ther. 2001 May;1(3):481-95. doi: 10.1517/14712598.1.3.481. Expert Opin Biol Ther. 2001. PMID: 11727520 Review.

5

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.

Nasu Y, Bangma CH, Hull GW, Yang G, Wang J, Shimura S, McCurdy MA, Ebara S, Lee HM, Timme TL, Thompson TC. Nasu Y, et al. Among authors: yang g. Prostate Cancer Prostatic Dis. 2001;4(1):44-55. doi: 10.1038/sj.pcan.4500494. Prostate Cancer Prostatic Dis. 2001. PMID: 12497062

6

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.

Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC. Ebara S, et al. Among authors: yang g. Prostate Cancer Prostatic Dis. 2002;5(4):316-25. doi: 10.1038/sj.pcan.4500610. Prostate Cancer Prostatic Dis. 2002. PMID: 12627218

7

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.

Fujita T, Timme TL, Tabata K, Naruishi K, Kusaka N, Watanabe M, Abdelfattah E, Zhu JX, Ren C, Ren C, Yang G, Goltsov A, Wang H, Vlachaki MT, Teh BS, Butler EB, Thompson TC. Fujita T, et al. Among authors: yang g. Gene Ther. 2007 Feb;14(3):227-36. doi: 10.1038/sj.gt.3302788. Epub 2006 Oct 5. Gene Ther. 2007. PMID: 17024109

8

Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.

Tabata K, Watanabe M, Naruishi K, Edamura K, Satoh T, Yang G, Abdel Fattah E, Wang J, Goltsov A, Floryk D, Soni SD, Kadmon D, Thompson TC. Tabata K, et al. Among authors: yang g. Prostate Cancer Prostatic Dis. 2009;12(3):301-9. doi: 10.1038/pcan.2008.57. Epub 2008 Dec 23. Prostate Cancer Prostatic Dis. 2009. PMID: 19104507

9

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G. Thompson TC, et al. Among authors: yang g. Oncogene. 1995 Mar 2;10(5):869-79. Oncogene. 1995. PMID: 7534899

10

DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.

Greene DR, Taylor SR, Aihara M, Yoshida K, Egawa S, Park SH, Timme TL, Yang G, Scardino PT, Thompson TC. Greene DR, et al. Among authors: yang g. Int J Cancer. 1995 Jan 27;60(3):395-9. doi: 10.1002/ijc.2910600321. Int J Cancer. 1995. PMID: 7829250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,697 results

Search Page